Tirelli Claudio, Parazzini Elena Maria, Sacchi Lucia, Carone Giulia, Pescol Francesca, Maggioni Sara, Belmonte Luca Alessandro, Albrici Cristina, Contino Simone, Re Beatrice, Mosole Benedetta, Mondoni Michele, Centanni Stefano
Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, 20142 Milan, Italy.
Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, 20142 Milan, Italy.
Respir Med. 2025 Oct;247:108260. doi: 10.1016/j.rmed.2025.108260. Epub 2025 Jul 16.
Severe asthma affects 3-10 % of asthmatic patients. Biologic therapies can act as disease modifying agents in severe asthma. The prevalence of small airways dysfunction (SAD) increases with asthma severity. Forced Oscillatory Technique (FOT) is a reliable method for studying small airways. The aim of the study was to analyze FOT parameters in a cohort of eosinophilic severe asthma patients naïve of biologic therapy, and to describe the presence of correlation with spirometry data. Variations of FOT parameters after 6 and 12 months from the start of biologic therapy were also prospectively recorded and analyzed.
47 severe eosinophilic asthma patients were consecutively enrolled. FOT, spirometry data, levels of asthma biomarkers, number of exacerbations, Asthma Control Test (ACT) were determined at baseline (T0: patients naïve of biologic treatment) and after 6 and 12 months.
at T0, a significant linear correlation was found between R5-19 and FEV1/FVC (Forced expiratory volume in 1 s/Forced Vital Capacity) values (p = 0.0008). At T0, FOT R5-19 values were more elevated in obstructed patients. The cut-off value of R5-19 that best discriminates the presence of obstruction (FEV1/FVC <0.70) was determined at 0.81 cmHO/(L/s) (sensitivity 0.58, specificity 0.76, ROC-AUC 0.67). A significant relationship was found between FEV1/FVC and FOT R5-19 also after 6 (p = 0.007) and 12 months (p = 0.027) of biologic therapy. No significant correlations were found between any other FOT parameter and blood eosinophils count, FeNO, number of exacerbations or ACT.
FOT R5-19 values correlate with FEV1/FVC and are significantly higher in obstruction. This correlation could be explained by the higher resistances of small airways in obstructed patients.
重度哮喘影响3%-10%的哮喘患者。生物疗法可作为重度哮喘的疾病改善药物。小气道功能障碍(SAD)的患病率随哮喘严重程度增加。强迫振荡技术(FOT)是研究小气道的可靠方法。本研究的目的是分析一组未接受生物疗法的嗜酸性粒细胞性重度哮喘患者的FOT参数,并描述其与肺量计数据的相关性。还前瞻性记录并分析了生物疗法开始后6个月和12个月时FOT参数的变化。
连续纳入47例重度嗜酸性粒细胞性哮喘患者。在基线(T0:未接受生物治疗的患者)以及6个月和12个月后测定FOT、肺量计数据、哮喘生物标志物水平、急性加重次数、哮喘控制测试(ACT)。
在T0时,发现R5-19与FEV1/FVC(一秒用力呼气量/用力肺活量)值之间存在显著线性相关性(p = 0.0008)。在T0时,阻塞性患者的FOT R5-19值更高。区分阻塞(FEV1/FVC <0.70)的最佳R5-19临界值确定为0.81 cmHO/(L/s)(敏感性0.58,特异性0.76,ROC-AUC 0.67)。生物疗法6个月(p = 0.007)和12个月(p = 0.027)后,FEV1/FVC与FOT R5-19之间也存在显著关系。未发现任何其他FOT参数与血嗜酸性粒细胞计数、呼出一氧化氮(FeNO)、急性加重次数或ACT之间存在显著相关性。
FOT R5-19值与FEV1/FVC相关,且在阻塞时显著更高。这种相关性可以用阻塞性患者小气道阻力较高来解释。